Product Details for NDA 018445
DOLOBID (DIFLUNISAL)
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: DIFLUNISAL
Proprietary Name: DOLOBID
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018445
Product Number: 001
Approval Date: Apr 19, 1982
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status: Discontinued
Patent and Exclusivity Information
DOLOBID (DIFLUNISAL)
Proprietary Name: DOLOBID
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018445
Product Number: 001
Approval Date: Apr 19, 1982
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: DIFLUNISAL
Proprietary Name: DOLOBID
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018445
Product Number: 002
Approval Date: Apr 19, 1982
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: DOLOBID
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018445
Product Number: 002
Approval Date: Apr 19, 1982
Applicant Holder Full Name: MERCK AND CO INC
Marketing Status: Discontinued
Patent and Exclusivity Information